NeuroPace Inc
Qualité des données : 100%
NPCE
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
14,26 €
▼
0,39 €
(-2,66%)
Cap. Boursière: 480,09 M
Prix
14,26 €
Cap. Boursière
480,09 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 21,97% annually over 5 years — strong growth
Debt/Equity of 3,17 — high leverage
Negative free cash flow of -11,34 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,16%
Capital efficient — spends only 0,33% of revenue on capex
Croissance
Revenue Growth (5Y)
21,97%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)25,13%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-113,10%
En dessous de la moyenne du secteur (-53,34%)
ROIC-14,62%
Net Margin-21,47%
Op. Margin-16,34%
Sécurité
Debt / Equity
3,17
Au-dessus de la moyenne du secteur (0,31)
Current Ratio4,86
Interest Coverage-2,19
Valorisation
PE (TTM|NTM)
-22,37 | -40,36
En dessous de la moyenne du secteur (-1,47)
P/B Ratio25,93
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -22,4 | -1,5 |
| P/B | 25,9 | 1,6 |
| ROE % | -113,1 | -53,3 |
| Net Margin % | -21,5 | -41,5 |
| Rev Growth 5Y % | 22,0 | 1,8 |
| D/E | 3,2 | 0,3 |
Objectif de Cours des Analystes
8 analystes
Buy
Actuel
14,26 €
Objectif
19,88 €
18,00 €
20,00 €
22,00 €
Prévisions
P/E Prévisionnel
-40,36
BPA Prévisionnel
-0,35 €
CA Est.
123,08 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,35 €
-0,68 € – -0,06 €
|
123,08 M | 6 |
| FY2026 |
-0,60 €
-0,79 € – -0,38 €
|
98,91 M | 7 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,20 €
-0,24 € – -0,12 €
|
23,17 M | 7 |
| 2026 Q1 |
-0,22 €
-0,29 € – -0,18 €
|
21,65 M | 7 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,15 € | -0,08 € | +48,1% |
| Q32025 | -0,19 € | -0,11 € | +43,6% |
| Q22025 | -0,22 € | -0,26 € | -19,8% |
| Q12025 | -0,24 € | -0,21 € | +10,7% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25,13% | Revenue Growth (3Y) | 23,63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 21,97% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 99,99 M | Net Income (TTM) | -21,47 M |
| ROE | -113,10% | ROA | -20,12% |
| Gross Margin | 77,23% | Operating Margin | -16,34% |
| Net Margin | -21,47% | Free Cash Flow (TTM) | -11,34 M |
| ROIC | -14,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3,17 | Current Ratio | 4,86 |
| Interest Coverage | -2,19 | Asset Turnover | 0,94 |
| Working Capital | 75,72 M | Tangible Book Value | 18,52 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -22,37 | Forward P/E | -40,36 |
| P/B Ratio | 25,93 | P/S Ratio | 4,80 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 3,90 | Fwd Earnings Yield | N/A |
| FCF Yield | -2,36% | ||
| Market Cap | 480,09 M | Enterprise Value | 518,19 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,66 | Revenue / Share | 2,97 |
| FCF / Share | -0,34 | OCF / Share | -0,33 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,33% | FCF Conversion | 52,82% |
| SBC-Adj. FCF | -22,41 M | Growth Momentum | 3,16 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 99,99 M | 79,91 M | 65,42 M | 45,52 M | 45,18 M |
| Net Income | -21,47 M | -27,14 M | -32,96 M | -47,08 M | -36,08 M |
| EPS (Diluted) | -0,66 | -0,93 | -1,27 | -1,91 | -2,17 |
| Gross Profit | 77,22 M | 59,09 M | 48,12 M | 32,49 M | 33,44 M |
| Operating Income | -16,34 M | -21,67 M | -27,17 M | -40,79 M | -23,74 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 27,89 M | 23,65 M | 20,78 M | 21,95 M | 18,21 M |
| SG&A Expenses | — | 57,10 M | 54,52 M | 51,34 M | 38,96 M |
| D&A | — | — | — | — | — |
| Interest Expense | 7,46 M | 8,80 M | 8,52 M | 7,53 M | 7,41 M |
| Income Tax | 0,0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 105,57 M | 94,65 M | 107,65 M | 114,11 M | 133,56 M |
| Total Liabilities | 86,53 M | 86,63 M | 87,00 M | 79,33 M | 60,06 M |
| Shareholders' Equity | 19,03 M | 8,01 M | 20,65 M | 34,78 M | 73,50 M |
| Total Debt | 58,88 M | 59,53 M | 56,95 M | 52,91 M | 49,85 M |
| Cash & Equivalents | 21,69 M | 13,43 M | 18,06 M | 6,61 M | 19,19 M |
| Current Assets | 94,07 M | 81,34 M | 92,72 M | 97,71 M | 132,82 M |
| Current Liabilities | 17,81 M | 15,16 M | 16,23 M | 10,98 M | 9,30 M |
{"event":"ticker_viewed","properties":{"ticker":"NPCE","listing_kind":"stock","pathname":"/stocks/npce","exchange":"Nasdaq","country":"US"}}